Key statistics
On Tuesday, Evogene Ltd (EVGN:TLV) closed at 1,189.00, 28.99% above the 52 week low of 921.80 set on Sep 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1,130.00 |
---|---|
High | 1,220.00 |
Low | 1,124.00 |
Bid | 1,148.00 |
Offer | 1,189.00 |
Previous close | 1,117.00 |
Average volume | 11.84k |
---|---|
Shares outstanding | 5.06m |
Free float | 4.97m |
P/E (TTM) | -- |
Market cap | 14.97m USD |
EPS (TTM) | -3.94 USD |
Data delayed at least 20 minutes, as of Oct 01 2024 15:24 BST.
More ▼
Press releases
- Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
- Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
- Evogene Reports Second Quarter 2024 Financial Results
- Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
- Evogene Schedules Second Quarter 2024 Financial Results Release
- Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil
- Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
- ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
More ▼